UNSPSC 51352000: Estrogen, progestin, or internal contraceptive norpregnenes

Estrogens, progestins, or internal contraceptives made from pregnenes with one double bond or more than three double bonds which have undergone ring contractions or are lacking carbon-18 or carbon-19.

UNSPSC 51352000 Estrogen, progestin, or internal contraceptive norpregnenes is a Class code encompassing pharmaceutical products within the contraceptive family that state and local governments procure for distribution through public health systems, clinics, and healthcare facilities. The recent activity under this code reflects broad pharmaceutical procurement rather than narrowly specialized contraceptive products; the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP in January 2026 for generic multi-source pharmaceuticals and over-the-counter products with proposals due March 26, 2026. This cooperative purchasing vehicle serves multiple state and local government entities across participating jurisdictions, including Oregon, and awards multiple contracts based on therapeutic considerations, product availability, and member-specific needs. Vendors must maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC), comply with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and carry insurance coverage including $5 million commercial general liability and $2 million network security and privacy liability. Evaluation emphasizes price competitiveness (75 percent) alongside compliance with administrative requirements, EDI capability, and adherence to specified pricing formats.

MMCAP's multistate cooperative vehicle represents the primary recent signal of activity under this code, spanning state and local government procurement across the Upper Midwest and Pacific Northwest. The RFP specified that awarded vendors would be provided to authorized wholesalers by May 15, 2026, with resulting agreements effective July 1, 2026; the contract term runs two years for new responders with optional extensions at MMCAP's discretion, while incumbent amendments align through June 30, 2028. Vendors face performance penalties ranging from $200 to $1,500 per violation for issues such as late reporting or missed onboarding timelines and must pay a 3 percent administrative fee on all contract purchases. No specific set-aside designations or disadvantaged-enterprise restrictions were identified in the RFP documentation; award values or budget ranges were not disclosed.